Matches in Wikidata for { <http://www.wikidata.org/entity/Q62062961> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q62062961 description "clinical trial" @default.
- Q62062961 description "ensayu clínicu" @default.
- Q62062961 description "klinisch onderzoek" @default.
- Q62062961 description "клінічне випробування" @default.
- Q62062961 name "Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes." @default.
- Q62062961 type Item @default.
- Q62062961 label "Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes." @default.
- Q62062961 prefLabel "Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes." @default.
- Q62062961 P1050 Q62062961-59EACB49-FC09-4F79-A077-86214A032192 @default.
- Q62062961 P1050 Q62062961-CE4328A7-47FD-4E35-B1D9-112F1049EBE5 @default.
- Q62062961 P1132 Q62062961-147D3F42-5D60-4D9D-ADC5-EB3FD3A1C727 @default.
- Q62062961 P1476 Q62062961-A016C098-F595-4708-B8D6-20123DDB0AAC @default.
- Q62062961 P17 Q62062961-A375C564-6DF5-4851-A4F1-62311DAB2062 @default.
- Q62062961 P1813 Q62062961-C8C52894-3EAC-4183-8F05-C6F26858159B @default.
- Q62062961 P3098 Q62062961-7ADB1239-16B7-4882-A998-FA8305611876 @default.
- Q62062961 P31 Q62062961-6FC6406E-1645-4AF3-A40B-93621B79E910 @default.
- Q62062961 P4844 Q62062961-2B4FD830-8DAC-43FC-9884-D820E1F4089E @default.
- Q62062961 P4844 Q62062961-624791ED-D7B2-4A5B-A545-A7193C1D3E1B @default.
- Q62062961 P4844 Q62062961-A43D8425-063B-46FA-AD8F-BCD6706CD495 @default.
- Q62062961 P580 Q62062961-4559FE68-D43A-4B40-ADEA-4B3D95B3F540 @default.
- Q62062961 P582 Q62062961-9B218214-2246-47D5-945E-89A5214831C8 @default.
- Q62062961 P6099 Q62062961-F13D30A2-3F16-4894-A7BB-D365A8E4161D @default.
- Q62062961 P6153 Q62062961-974D00D9-69AA-46FC-96B2-9C24F261F8B7 @default.
- Q62062961 P8363 Q62062961-4CE43183-405D-49AF-B386-1239DB7CCEAB @default.
- Q62062961 P859 Q62062961-F8AE49CB-8227-41BD-9E76-007D629D721A @default.
- Q62062961 P921 Q62062961-D604FB29-5C56-4377-B703-9EB4D867DC67 @default.
- Q62062961 P1050 Q12206 @default.
- Q62062961 P1050 Q41861 @default.
- Q62062961 P1132 "+45" @default.
- Q62062961 P1476 "A Double-blind, Randomized, Parallel 2- Arm Study to Compare the Efficacy of Ertugliflozin Versus Hydrochlorothiazide in Reducing Sympathetic Neural Overactivity in Patients With Hypertension and Recently-diagnosed Type 2 Diabetes Who Are Receiving Background Standard-of-care Cardio-metabolic Therapy With Metformin, an Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker, and a Statin." @default.
- Q62062961 P17 Q30 @default.
- Q62062961 P1813 "Ertugliflozin" @default.
- Q62062961 P3098 "NCT03640221" @default.
- Q62062961 P31 Q30612 @default.
- Q62062961 P4844 Q288280 @default.
- Q62062961 P4844 Q423930 @default.
- Q62062961 P4844 Q50430355 @default.
- Q62062961 P580 "2018-09-01T00:00:00Z" @default.
- Q62062961 P582 "2020-05-31T00:00:00Z" @default.
- Q62062961 P6099 Q42825046 @default.
- Q62062961 P6153 Q1052562 @default.
- Q62062961 P8363 Q78089383 @default.
- Q62062961 P859 Q1052562 @default.
- Q62062961 P921 Q12206 @default.